Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

INDUSTRY 129OTHER 113NIH 8NETWORK 2UNKNOWN 1OTHER_GOV 1FED 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 4Head & Neck 1Dermatologic 1

Conditions

Head and Neck Neoplasms 6Deglutition Disorders 3Neoplasms 2Tinnitus 1Respiratory Aspiration 1Recurrence 1Ototoxicity 1Oropharyngeal Neoplasms 1Neoplasm Metastasis 1Mouth Neoplasms 1Hearing Loss, Sensorineural 1Hearing Loss 1Esophageal Stenosis 1Drug-Related Side Effects and Adverse Reactions 1Carcinoma, Squamous Cell 1Bites and Stings 1

Interventions

Oxaliplatin 1Docetaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
FED × Neoplasm Metastasis × Head & Neck × Clear all
NCT00557206 2013-11-05

Oxaliplatin and Docetaxel for Recurrent or Metastatic Head and Neck Cancer

Minneapolis Veterans Affairs Medical Center

Phase 2 Terminated
35 enrolled
Head & Neck

Carcinoma, Squamous Cell, Head and Neck Neoplasms, Neoplasm Metastasis, Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡